Siemens (NSE:SIEMENS, BOM:500550) has completed the sale of its low-voltage motors and geared motors business, including the related customer service operations, to Innomotics India, according to a Monday filing to the Indian bourses.
Siemens had agreed to sell its low-voltage motors business to Innomotics India in December 2025 for 22 billion Indian rupees as a going concern on a slump sale basis.
(Updates with the stock movement in the headline and the last paragraph)Star Entertainment Group (ASX:SGR) said its Sydney casino was fined a total of AU$10 million by the New South Wales Independent Casino Commission (NICC) over multiple compliance breaches and must set aside a further AU$5 million to strengthen financial crime risk management technology, according to an Australian bourse filing on Monday after market hours.The penalties comprise AU$1.5 million for allowing patrons to gamble beyond permitted time limits, AU$3 million for enabling the conversion of casino reward points into cash, AU$500,000 for failing to prevent an excluded patron from entering the casino on nine occasions, and AU$5 million for widespread shortcomings in financial crime risk management, per the filing.The NICC acknowledged major improvements under the company's new leadership and technology upgrades but said the penalties reflect the serious breaches that exposed customers to gambling harm and increased the risk of criminal infiltration, the filing added.The company's shares climbed 3% in recent Tuesday trade.
Livzon Pharmaceutical's (HKG:1513, SHE:000513) unit Livzon MABPharm received approval from China's National Medical Products Administration for Recombinant Human Follitropin Alfa Solution for Injection, according to a Monday Hong Kong bourse filing.The product is indicated for anovulation, including polycystic ovary syndrome, ovarian stimulation in assisted reproductive technology procedures, and certain patients with severe luteinizing hormone and follicle-stimulating hormone deficiencies.The drug is administered through a pre-filled injection pen and was developed as a biosimilar.
Retail trade shares gained the most on New Zealand's Exchange, rising past 1% by midday Tuesday.Shares of Green Cross Health (NZE:GXH) surged 40% in recent trade.The company on Tuesday said it has entered into a conditional agreement to sell its medical division, The Doctors, to Tend Health for NZ$270 million, subject to adjustments for net debt and working capital.Meanwhile, the finance sector declined by more than 2%.Infratil (NZE:IFT, ASX:IFT) was down almost 1% in recent trade after the company said it launched an offer of up to NZ$150 million of unsecured, subordinated capital bonds due 2057 to investors in New Zealand.